Why Bill Gates is betting on a start-up that prints synthetic DNA
May 22, 2018 at 06:00 AM EDT
Bill Gates is investing in Ginkgo Bioworks, a Boston-based start-up that prints its own designer DNA from a computer and is developing one of the world's largest libraries of usable genetic code.
